RNS Number : 5073P
Zotefoams PLC
22 May 2024
 

Zotefoams plc

('the Company')

 

Result of the 2024 Annual General Meeting

 

22 May 2024 - The Company announces that at its Annual General Meeting held on 22 May 2024 at its offices at 675 Mitcham Road, Croydon CR9 3AL, all of the resolutions tabled at the meeting were passed on a poll vote. Resolutions 1 to 13 inclusive were passed as ordinary resolutions and resolutions 14 to 17 inclusive were passed as special resolutions. 

 

The total number of ordinary shares in issue in relation to the AGM is 48,846,234. Votes were cast by shareholders in respect of 28,504,200 ordinary shares amounting to 58.35% of the issued share capital.

 

The votes cast* were recorded as follows:

 

Resolution

For

% of votes cast

Against

% of votes cast

Votes Withheld

1.

To receive the Annual Report of the Company for the year ended 31 December 2023

28,500,344

100.00

-

0.00

3,856

2

To approve the Annual Statement by the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2023 set out on pages 90 to 103 of the Annual Report.

27,375,656

96.07

1,121,323

3.93

7,221

3

To declare a final dividend for the year ended 31 December 2023 of 4.90 pence per ordinary share, such dividend to be payable on 3 June 2024 to shareholders on the register of members of the Company at the close of business on 3 May 2024.

28,504,200

100.00

-

0.00

-

4

To re-elect L Drummond as a Director.

27,361,612

95.99

1,141,866

4.01

722

5.

To elect R M Cox as a Director.

28,383,334

100.00

146

0.00

120,720

6. 

To re-elect G C McGrath as a Director.

28,500,198

100.00

146

0.00

3,856

7

To re-elect J D Carling as a Director.

28,234,204

99.06

269,274

0.94

722

8. 

To re-elect D G Robertson as a Director.

28,231,068

99.06

269,274

0.94

3,858

9. 

To elect M S Swift as a Director.

28,382,581

100.00

899

0.00

120,720

10. 

To re-elect C A Wall as a Director.

28,230,544

99.04

272,935

0.96

721

11.

To re-appoint PKF Littlejohn LLP as Auditor of the Company.

28,380,834

99.99

2,646

0.01

120,720

12.

To authorise the Audit Committee to determine the Auditor's remuneration.

28,500,834

100.00

146

0.00

3,220

13.

To authorise the Directors to allot shares.

28,365,815

99.56

124,346

0.44

14,039

14.

To authorise the Directors to allot equity securities for cash.

28,374,893

99.57

123,682

0.43

5,625

15.

To authorise the Directors, in addition to resolution 14, to allot further equity securities for financing (and refinancing) purposes only.

28,378,719

99.57

122,556

0.43

2,925

16.

To authorise market purchases of shares.

28,501,980

99.99

2,220

0.01

-

17.

That a general meeting other than an annual general meeting may be called on not less than 14 clear days' notice.

27,637,020

96.96

867,179

3.04

1

 

*  Total votes cast excludes votes withheld as a vote withheld is not a vote in law.

 

Further details of the resolutions (including the text of the resolutions) are given in the Notice of the 2024 Annual General Meeting, which is on page 161 of the 2023 Annual Report and which is also available on the Company's website.

 

Pursuant to Listing Rule 9.6, the Company also confirms that a copy of all relevant resolutions passed at its AGM will shortly be made available for public inspection via the National Storage Mechanism.

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE® polyolefin and ZOTEK® high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT® advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce® mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA, Stilling, Denmark (microcellular foam technology) and Jiangsu Province, China (T-FIT).

www.zotefoams.com

AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFIVEIIFFIS
Zotefoams (LSE:ZTF)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Zotefoams 차트를 더 보려면 여기를 클릭.
Zotefoams (LSE:ZTF)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Zotefoams 차트를 더 보려면 여기를 클릭.